Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697.

Abstract	New antimalarial drugs are urgently needed. The use of short courses of the new antimalarial drug artemether as monotherapy has been limited by secondary malaria episodes following parasite clearance. Therefore, a new antimalarial drug, CGP 56697, has been developed, which combines artemether with a longer-acting antimalarial agent, benflumetol. A safety trial was undertaken in 60 Gambian children 1-6 years old with uncomplicated Plasmodium falciparum malaria. All children treated with CGP 56697 cleared their parasites 72 h after the start of treatment. No neurologic, cardiac, or other adverse reactions were observed. Second episodes of falciparum malaria were recorded in 16 (27%) of the children. Second infections were more frequent during the rainy season than during the dry season. Molecular epidemiologic studies suggested that 12 of the 14 second episodes of malaria in children treated with CGP 56697 were due to new infections. CGP 56697 proved to be a safe and effective antimalarial drug in African children.
Authors	L von Seidlein, S Jaffar, M Pinder, M Haywood, G Snounou, B Gemperli, I Gathmann, C Royce, B Greenwood
Journal	The Journal of infectious diseases (J Infect Dis) Vol. 176 Issue 4 Pg. 1113-6 (Oct 1997) ISSN: 0022-1899 [Print] United States
PMID	9333180 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Antimalarials Artemether, Lumefantrine Drug Combination Artemisinins DNA, Protozoan Drug Combinations Ethanolamines Fluorenes Sesquiterpenes Lumefantrine
Topics	Animals Antimalarials (administration & dosage, adverse effects, therapeutic use) Artemether, Lumefantrine Drug Combination Artemisinins Child Child, Preschool DNA, Protozoan (analysis) Drug Combinations Ethanolamines (administration & dosage, adverse effects, therapeutic use) Fluorenes (administration & dosage, adverse effects, therapeutic use) Gambia (epidemiology) Humans Infant Lumefantrine Malaria, Falciparum (drug therapy, epidemiology) Molecular Epidemiology Plasmodium falciparum (genetics) Polymerase Chain Reaction Polymorphism, Genetic Recurrence Seasons Sesquiterpenes (administration & dosage, adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!